Eli Lilly and Novo Nordisk develop weekly insulin
A patient injects herself with an insulin pen. Guido Krzikowski | Bloomberg | fake images Do you think a friend…
Eli Lilly and company
Eli Lilly shares hit new highs after a regulatory victory in China. This is a big problem
Every weekday, the CNBC Investing Club with Jim Cramer hosts a “Morning Meeting” livestream at 10:20 a.m. ET. Here's a…
AstraZeneca will increase its revenues and launch new drugs by 2030
Astrazeneca's logo appears at the 2021 World Artificial Intelligence Conference in Shanghai, China on July 7, 2021. Costofoto | Future…
Roche's weight-loss drug shows promising results in early trial
A logo at the headquarters of Roche Holding AG in Basel, Switzerland, Thursday, February 1, 2024. Bloomberg | fake images…
1 in 8 adults have taken GLP-1 like Ozempic: survey
Rebekah Carl poses with her Wegovy recipe in New Columbia, Pennsylvania, USA, November 13, 2023. Hannah Beier | Reuters Do…
Wegovy Patients Maintain Weight Loss for 4 Years: Novo Nordisk Study
Boxes of Wegovy manufactured by Novo Nordisk in a pharmacy in London, Britain, on March 8, 2024. Hollie Adams |…
Eli Lilly and Novo Nordisk increase the offer of weight loss drugs
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is displayed in New York City, U.S., on December 11,…
Why Eli Lilly's Profits Aren't a Sure Thing for Marketers Despite Obesity Drug Push
Eli Lilly appears to be making as many of its popular obesity and diabetes drugs as possible, but shortages are…
Eli Lilly (LLY) earnings in the first quarter of 2024
The Eli Lilly logo is displayed at one of the company's offices in San Diego, California, U.S., on September 17,…
Unjustified drop after GEHC results is a buying opportunity
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…